Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    It’s time to bet more strategically on AI in healthcare

    May 8, 2026

    How caffeine changes the human brain’s electrical braking system

    May 8, 2026

    AbbVie’s Skyrizi regains top spot in April ad spend rankings

    May 8, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Health Magazine
    • Home
    • Environmental Health
    • Health Technology
    • Medical Research
    • Mental Health
    • Nutrition Science
    • Pharma
    • Public Health
    • Discover
      • Daily Health Tips
      • Financial Health & Stability
      • Holistic Health & Wellness
      • Mental Health
      • Nutrition & Dietary Trends
      • Professional & Personal Growth
    • Our Mission
    Health Magazine
    Home » News » AbbVie’s Skyrizi regains top spot in April ad spend rankings
    Pharma

    AbbVie’s Skyrizi regains top spot in April ad spend rankings

    healthadminBy healthadminMay 8, 2026No Comments6 Mins Read
    AbbVie’s Skyrizi regains top spot in April ad spend rankings
    Share
    Facebook Twitter Reddit Telegram Pinterest Email


    In March, it lost the top spot to Johnson & Johnson’s immunotherapy drug Tremfya, but AbbVie’s rival drug Skyrizi has regained the top spot in advertising.

    AbbVie spent $46.8 million advertising Skyridi in April, an increase of $4.7 million from the previous month, putting the drug comfortably ahead of Tremfya.

    J&J’s drugs came in second with the biggest spending cut of $10.6 million, according to data shared by iSpot.tv analysts with Fierce Pharma Marketing.

    AbbVie’s other leading immunologist, Rinvoke, held onto third place in April, but in a close race with J&J, Rinvoke’s ad spend was just $200,000 behind Tremfya.

    Eli Lilly increased spending on its obesity drug Zepbound by $1.5 million, pushing the drug up one spot from March to No. 4.

    Up two spots to No. 5 is Sanofi and Regeneron’s immunology blockbuster Dupixent, with most of the $20.4 million spent last month on advertising related to its eczema indication.

    Johnson & Johnson returned to the list with its atypical antipsychotic drug Caprita, but fell two spots to No. 6 as spending fell from $23.4 million in March to $20.2 million in April.

    Lundbeck and Otsuka Pharmaceutical’s depression drug Rexulti came in seventh place, while Eli Lilly and Boehringer Ingelheim’s diabetes and kidney disease drug Jardiance moved from sixth place in March to eighth place due to an $8.2 million drop in spending.

    The final two spots went to AbbVie’s atypical antipsychotic Vreilor (which dropped from the rankings in March but returned to ninth place) and Neurocline’s Ingrezza, which is approved to treat tardive dyskinesia and chorea associated with Huntington’s disease.

    See April’s biggest ad spenders below, based on data compiled by iSpot.tv’s analysts.

    1. Skiriji

    Movement: move up one rank

    What is it? AbbVie’s immunotherapy

    EST (Eastern Standard Time). National linear TV advertising costs: $46.8 million (up from $42.1 million in March)

    • UC/Crohn’s disease: $21.4 million
    • Psoriasis: $22.9 million
    • Psoriatic arthritis: $2.5 million

    Top TV networks by share of voice spend (SOV):ABC (23.18%)

    Spending SOV Top TV Shows by: Sports center (2.19%)

    Number of spots: 5 patients (1 patient with psoriatic arthritis, 2 patients with psoriasis, 2 patients with UC/Crohn’s disease)

    Biggest ticket ad: “I’m All In: Swimming Pool” (estimated at $21.4 million)

    2. Tremfia

    Movement: went down one

    What is it? johnson & johnson immunotherapy

    EST (Eastern Standard Time). National linear TV advertising costs: $39.7 million (down from $50.3 million in March)

    • UC/Crohn’s disease: $25.8 million
    • Psoriasis: $1.2 million
    • Psoriatic arthritis: $12.8 million

    Top TV Networks by SOV Spending: ABC (19.76%)

    Spending SOV Top TV Shows by: Men’s College Basketball (7.60%)

    Number of spots: 8 patients (3 with psoriatic arthritis, 1 with psoriasis, 4 with UC/Crohn’s disease)

    Biggest ticket ad: “Relentless Weed” (est. $12.7 million)

    3. Revocation

    Movement: no movement

    What is it? AbbVie’s JAK inhibitor immunotherapy

    EST (Eastern Standard Time). National linear TV advertising costs: $39.5 million (up from $36.3 million in March)

    • Arthritis: $10 million
    • Eczema: $11.2 million
    • UC/Crohn’s disease: $18.3 million

    Top TV Networks by SOV Spending: ABC (27.52%)

    Spending SOV Top TV Shows by: Today (4.50%)

    Number of spots: 7 cases (2 arthritis, 2 ulcerative colitis/Crohn’s disease, 3 eczema)

    Biggest ticket ad: “Classic cars, tennis, and the fire department” (estimated at $18.2 million)

    4. Zep Bound

    Movement: move up one rank

    What is it? Eli Lilly’s obesity treatment

    EST (Eastern Standard Time). National linear TV advertising costs: $24.4 million (up from $22.9 million in March)

    Top TV Networks by SOV Spending:CBS (20.16%)

    Spending SOV Top TV Shows by: Men’s college basketball (30.23%)

    Number of spots: Seven

    Biggest ticket ad: “Watch This: Head-to-Head” (estimated at $13.1 million)

    5. Dupixent

    Movement: Moved up 2 places

    What is it? Sanofi and Regeneron’s immunotherapy

    EST (Eastern Standard Time). National linear TV advertising costs: $20.4 million (up from $19.6 million in March)

    • Eczema: $13.7 million
    • Asthma: $6.7 million
    • Gastrointestinal: $36.5,000

    Top TV Networks by SOV Spending: ABC (32.31%)

    Spending SOV Top TV Shows by: Men’s college basketball (6.57%)

    Number of spots: 8 cases (3 cases of asthma, 4 cases of eczema, 1 case of gastrointestinal disease)

    Biggest ticket ad: “Feel the Heel” (est. $8.2 million)

    6. Caprita

    Movement: Moved down 2 places

    What is it? Johnson & Johnson’s atypical antipsychotic

    EST (Eastern Standard Time). National linear TV advertising costs: $20.2 million (down from $23.4 million in March)

    Top TV Networks by SOV Spending:ABC (19.61%)

    Spending SOV Top TV Shows by: 2026 NFL Draft (4.91%)

    Number of spots: three

    Biggest ticket ad: “Let in the Lyte: More Relief” (estimated at $7.5 million)

    7. Rejected

    Movement: move up one rank

    What is it? Lundbeck-Otsuka nerve drug

    EST (Eastern Standard Time). National linear TV advertising costs: $17.8 million (up from $16.5 million in March)

    Top TV Networks by SOV Spending:CBS (16.32%)

    Spending SOV Top TV Shows by: NCIS (4.32%)

    Number of spots: two

    Biggest ticket ad: “Progress” (estimated at $17.8 million)

    8. Jardiance

    Movement: Moved down 2 places

    What is it? Eli Lilly and Boehringer Ingelheim’s diabetes and kidney disease treatments

    EST (Eastern Standard Time). National linear TV advertising costs: $12.6 million (down from $20.8 million in March)

    • CKD: 3 million dollars
    • Diabetes: $9.7 million

    Top TV Networks by SOV Spending: ABC (20.55%)

    Spending SOV Top TV Shows by: ABC World News Tonight, David Muir (4.64%)

    Number of spots: 2 people (1 person with CKD, 1 person with diabetes)

    Biggest ticket ad: “Behind the Scenes” (estimated at $9.7 million)

    9. Vrayz

    Movement: Not posted last month

    What is it? AbbVie’s atypical antipsychotics

    EST (Eastern Standard Time). National linear TV advertising costs: $12.1 million (up from $10.5 million in March)

    • Bipolar disorder: $4.5 million
    • Depression: $7.6 million

    Top TV Networks by SOV Spending: ABC (9.68%)

    Spending SOV Top TV Shows by: NBA (6.54%)

    Number of spots: 3 people (2 with depression, 1 with bipolar disorder)

    Biggest ticket ad: “Jane’s Head” (est. $7.5 million)

    10. Dishonesty

    Movement: Not posted last month

    What is it? Neurosecretory tardive dyskinesia and chorea associated with Huntington’s disease drugs

    EST (Eastern Standard Time). National linear TV advertising costs: $11 million (up from $8 million in March)

    Top TV Networks by SOV Spending:CBS (19.09%)

    Spending SOV Top TV Shows by: ABC World News Tonight, David Muir (7.71%)

    Number of spots: two

    Biggest ticket ad: “Flowing Stories” (estimated at $11 million)



    Source link

    Visited 1 times, 1 visit(s) today
    Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
    Previous ArticleWhen men are sexually aroused, they treat women more as objects, regardless of their underlying personality traits.
    Next Article How caffeine changes the human brain’s electrical braking system
    healthadmin

    Related Posts

    Gilead raises first-year sales forecast for Eztugo to $1 billion on ‘unprecedented ramp-up trajectory’

    May 8, 2026

    Daiichi Sankyo takes $610 million profit hit due to ADC manufacturing overbuild

    May 8, 2026

    GSK launches Modern Family for Meningitis Messaging

    May 8, 2026

    Fierce Pharma Asia – Unexpected absence from the summit mid-term exam. UCB’s $2 billion straight acquisition. J&J’s CAR-T cut

    May 8, 2026

    Pre-launch initiatives that lead to lasting drug awareness: Report

    May 8, 2026

    Italian pharmaceutical company Angelini acquires Catalyst in $4.1 billion deal

    May 7, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Categories

    • Daily Health Tips
    • Discover
    • Environmental Health
    • Exercise & Fitness
    • Featured
    • Featured Videos
    • Financial Health & Stability
    • Fitness
    • Fitness Updates
    • Health
    • Health Technology
    • Healthy Aging
    • Healthy Living
    • Holistic Healing
    • Holistic Health & Wellness
    • Medical Research
    • Medical Research & Insights
    • Mental Health
    • Mental Wellness
    • Natural Remedies
    • New Workouts
    • Nutrition
    • Nutrition & Dietary Trends
    • Nutrition & Superfoods
    • Nutrition Science
    • Pharma
    • Preventive Healthcare
    • Professional & Personal Growth
    • Public Health
    • Public Health & Awareness
    • Selected
    • Sleep & Recovery
    • Top Programs
    • Weight Management
    • Workouts
    Popular Posts
    • 1773313737_bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpgHow Sino Biological ProPure™ redefines ultra-low… March 12, 2026
    • the-pros-and-cons-of-paleo-dietsThe Pros and Cons of Paleo Diets: What Science Really Says April 16, 2025
    • pexels-david-bartus-442116The food industry needs to act now to cut greenhouse… January 2, 2022
    • Improve Mental Health10 Science-Backed Practices to Improve Mental Health… March 11, 2025
    • 1773729862_TagImage-3347-458389964760995353448-620x480.jpgDespite safety concerns, parents underestimate the… March 17, 2026
    • 1773209206_futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_4.jpegMulti-agent AI systems outperform single models… March 11, 2026

    Demo
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    It’s time to bet more strategically on AI in healthcare

    By healthadminMay 8, 2026

    More than 230 million people use ChatGPT to ask health and wellness questions every week.…

    How caffeine changes the human brain’s electrical braking system

    May 8, 2026

    AbbVie’s Skyrizi regains top spot in April ad spend rankings

    May 8, 2026

    When men are sexually aroused, they treat women more as objects, regardless of their underlying personality traits.

    May 8, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    HealthxMagazine
    HealthxMagazine

    At HealthX Magazine, we are dedicated to empowering entrepreneurs, doctors, chiropractors, healthcare professionals, personal trainers, executives, thought leaders, and anyone striving for optimal health.

    Our Picks

    When men are sexually aroused, they treat women more as objects, regardless of their underlying personality traits.

    May 8, 2026

    Gilead raises first-year sales forecast for Eztugo to $1 billion on ‘unprecedented ramp-up trajectory’

    May 8, 2026

    Dozens of court briefs filed in Supreme Court mifepristone case

    May 8, 2026
    New Comments
      Facebook X (Twitter) Instagram Pinterest
      • Home
      • Privacy Policy
      • Our Mission
      © 2026 ThemeSphere. Designed by ThemeSphere.

      Type above and press Enter to search. Press Esc to cancel.